Eisai
4523.T
#2300
Rank
NZ$14.62 B
Marketcap
NZ$51.83
Share price
-0.60%
Change (1 day)
-1.88%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): NZ$1.42

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.55. In 2026 the company made an earnings per share (EPS) of NZ$1.54 a decrease over its 2025 EPS that were of NZ$1.95.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026NZ$1.54-21.04%
2025NZ$1.9511.85%
2024NZ$1.74-32.63%
2023NZ$2.595.52%
2022NZ$2.45-74.01%
2021NZ$9.44-66.58%
2020NZ$28.2498.24%
2019NZ$14.2417.01%
2018NZ$12.1737.78%
2017NZ$8.84-27.62%
2016NZ$12.2135.33%
2015NZ$9.02-2.82%
2014NZ$9.28-27.66%
2013NZ$12.83-27.49%
2012NZ$17.70-12.67%
2011NZ$20.2788.08%
2010NZ$10.78-11.06%
2009NZ$12.12-390.15%
2008NZ-$4.18-127.78%
2007NZ$15.03347.11%
2006NZ$3.364.38%
2005NZ$3.227.4%
2004NZ$3.0043.03%
2003NZ$2.1025.09%
2002NZ$1.6852.67%
2001NZ$1.1069.76%
2000NZ$0.65